National Health Act 1953 Amendment Determinations under sections 85, 85A and 88 Pharmaceutical Benefits (No. PB 7 of 2008) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 7 of 2008

Amendment determinations under sections 85, 85A and 88 of the National Health Act 1953

I, STEPHEN DELLAR, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under sections 85, 85A and 88 of the National Health Act 1953.

Dated 14 December 2007

STEPHEN DELLAR

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — pharmaceutical benefits

1              Commencement

This instrument commences on 1 January 2008.

2              Amendment of PB 89 of 2007

Schedule 1 amends PB 89 of 2007.

Schedule 1        Amendments

[1]           Part 1 of Schedule 1, item dealing with Amoxycillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL

omit from the column headed “Brand”:

Amohexal

[2]           Part 1 of Schedule 1, item dealing with Calcium

omit from the columns in the order indicated:

Tablet 600 mg (as carbonate) Oral 120 1 Caltrate

[3]           Part 1 of Schedule 1, item dealing with Cefaclor in the form Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

in the column headed “Brand” insert in alphabetical order:

Ozcef

[4]           Part 1 of Schedule 1, item dealing with Cefaclor in the form Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

in the column headed “Brand” insert in alphabetical order:

Ozcef

[5]           Part 1 of Schedule 1, item dealing with Cephalexin in the form Capsule 250 mg (anhydrous)

in the column headed “Brand” insert in alphabetical order:

Cephabell

[6]           Part 1 of Schedule 1, item dealing with Cephalexin in the form Capsule 500 mg (anhydrous)

in the column headed “Brand” insert in alphabetical order:

Cephabell

[7]           Part 1 of Schedule 1, item dealing with Ciprofloxacin in the form Tablet 500 mg (as hydrochloride)

omit from the column headed “Brand”:

Ciprofloxacin-BC

[8]           Part 1 of Schedule 1, item dealing with Glucose Indicator—Blood

(a) omit from the columns in the order indicated:

Electrode strips, 50 (Ascensia Elite) For external use 2 5 Ascensia Elite

(b) omit from the columns in the order indicated:

Discs containing electrode sensors, 10 sensors per disc, 5 For external use 2 5 Ascensia Glucodisc

[9]           Part 1 of Schedule 1, item dealing with Influenza Vaccine

insert immediately before the existing entry in the columns in the order indicated:

Injection containing inactivated, split virion influenza vaccine, 0.25 mL of which contains antigens representative of the following types: A/New Caledonia/20/99 (H₁N₁)-like strain 7.5 micrograms haemagglutinin; A/Wisconsin/67/2005 (H₃N₂)-like strain 7.5 micrograms haemagglutinin; B/Malaysia/2506/2004 like strain 7.5 micrograms haemagglutinin; 0.25 mL pre-filled syringe Injection 1 .. Vaxigrip Junior

[10]         Part 1 of Schedule 1, items dealing with Oestradiol

(a) omit from the columns in the order indicated:

Transdermal patches 3.28 mg, 8 Transdermal 1 5 Menorest 37.5

(b) omit from the columns in the order indicated:

Transdermal patches 4.33 mg, 8 Transdermal 1 5 Menorest 50

(c) omit from the columns in the order indicated:

Transdermal patches 6.57 mg, 8 Transdermal 1 5 Menorest 75

(d) omit from the columns in the order indicated:

Transdermal patches 8.66 mg, 8 Transdermal 1 5 Menorest 100

[11]         Part 1 of Schedule 1, item dealing with Paracetamol in the form Tablet 500 mg

in the column headed “Brand” insert in alphabetical order:

Paracetamol Sandoz

[12]         Part 1 of Schedule 1, item dealing with Paroxetine in the form Tablet 20 mg (as hydrochloride)

(a) omit from the column headed “Brand”:

Oxetine

(b) in the column headed “Brand” insert in alphabetical order:

Paroxetine Sandoz

[13]         Part 1 of Schedule 1, item dealing with Paroxetine in the form Tablet 20 mg (as hydrochloride)

in the column headed “Brand” insert in alphabetical order:

Paroxetine Winthrop

[14]         Part 1 of Schedule 1, item dealing with Pilocarpine

omit from the columns in the order indicated:

Eye drops containing pilocarpine hydrochloride 5 mg per mL, 15 mL Application to the eye 1 5 P.V.Carpine Pilopt

[15]         Part 1 of Schedule 1, item dealing with Sertraline in the form Tablet 50 mg (as hydrochloride)

in the column headed “Brand” insert in alphabetical order:

Sertraline generichealth

[16]         Part 1 of Schedule 1, item dealing with Sertraline in the form Tablet 100 mg (as hydrochloride)

in the column headed “Brand” insert in alphabetical order:

Sertraline generichealth

[17]         Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 10 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin generichealth

[18]         Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 20 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin generichealth

[19]         Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 40 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin generichealth

[20]         Part 1 of Schedule 1, item dealing with Simvastatin in the form Tablet 80 mg

in the column headed “Brand” insert in alphabetical order:

Simvastatin generichealth

[21]         Part 1 of Schedule 1, item dealing with Tamoxifen in the form Tablet 20 mg (as citrate)

omit from the column headed “Brand”:

Tamoxifen Hexal

and substitute:

Tamoxifen Sandoz

[22]         Part 1 of Schedule 1, omit items dealing with Thioridazine

[23]         Part 2 of Schedule 1, item dealing with Ciprofloxacin in the form Tablet 250 mg (as hydrochloride)

omit from the column headed “Brand”:

Ciprofloxacin-BC

[24]         Part 2 of Schedule 1, after item dealing with Lansoprazole in the form Capsule 30 mg

insert in the columns in the order indicated:

Sachet containing granules for oral suspension, 30 mg per sachet Gastro-oesophageal reflux disease Scleroderma oesophagus Oral 28 5 Zoton

[25]        Part 2 of Schedule 1, item dealing with Paracetamol in the form Tablet 500 mg

in the column headed “Brand” insert in alphabetical order:

Paracetamol Sandoz

[26]         Part 1 of Schedule 3, item dealing with Amoxycillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL

omit from the column headed “Brand”:

Amohexal

[27]         Part 1 of Schedule 3, item dealing with Cefaclor in the form Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

in the column headed “Brand” insert in alphabetical order:

Ozcef

[28]         Part 1 of Schedule 3, item dealing with Cefaclor in the form Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

in the column headed “Brand” insert in alphabetical order:

Ozcef

[29]         Part 1 of Schedule 3, item dealing with Cephalexin in the form Capsule 250 mg (anhydrous)

in the column headed “Brand” insert in alphabetical order:

Cephabell

[30]         Part 1 of Schedule 3, item dealing with Cephalexin in the form Capsule 500 mg (anhydrous)

in the column headed “Brand” insert in alphabetical order:

Cephabell

[31]         Part 1 of Schedule 3, item dealing with Paracetamol in the form Tablet 500 mg

in the column headed “Brand” insert in alphabetical order:

Paracetamol Sandoz

[32]         Part 2 of Schedule 3, item dealing with Paracetamol in the form Tablet 500 mg

in the column headed “Brand” insert in alphabetical order:

Paracetamol Sandoz